VIDEO: Troriluzole alters trajectory of spinocerebellar ataxia
DENVER — Four studies presented at the American Academy of Neurology annual meeting show improvements in patients with spinocerebellar ataxia who take troriluzole.“SCAs [spinocerebellar ataxias] are, at present, untreatable, inexorably progressive diseases,” Jeremy Schmahmann, MD, said in this Healio video. “We’re hoping for a therapeutic intervention that will